|
View this as a webpage
Minnesota Department of Health
June 23, 2022
CDC recommends COVID-19 vaccine for 6 months and older
On June 18, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendations that all children 6 months through 5 years should receive a COVID-19 vaccination. The schedule includes Moderna as a 2-dose primary series (0.25 mL, 25 mcg) for children 6 months through 5 years and Pfizer as a 3-dose primary series (0.2 mL, 3 mcg) for children 6 months through 4 years. An additional Moderna primary series dose for children in this age group who are immunocompromised is also recommended.
Since the beginning of the pandemic, there have been over 2 million cases, over 20,000 hospitalizations and over 200 deaths in children ages 6 months through 4 years. COVID-19 can cause severe disease and death among children, including children without underlying medical conditions. Both vaccines are safe and provide protection against severe disease and hospitalization.
For detailed vaccine information refer to the EUA factsheets at COVID-19 Vaccines. CDC has updated their Interim Clinical Consideration for Use of COVID-19 Vaccines along with a new infants and young children section and an At-A-Glance COVID-19 Vaccination Schedule. CDC’s Stay Up to Date with Your COVID-19 Vaccines has also been updated.
MDH has updated the Interim COVID-19 Vaccine Provider Guide, Template: COVID-19 Screening and Agreement and created the Pfizer-BioNTech COVID-19 Vaccine Protocol for 6 months through 4 years and Moderna COVID-19 Vaccine Protocol for 6 months through 5 years. Find these resources at COVID-19 Vaccine Providers.
Pfizer-BioNTech COVID-19 maroon cap label discrepancy
Pfizer-BioNTech COVID-19 vaccine for use in children 6 months through 4 years of age are supplied in multiple dose vials with maroon caps and labels with a maroon border. The vial labels may state “Age 2y to < 5y” or “Age 6m to < 5y” and carton labels may state “For age 2 years to < 5 years” or “For age 6 months to < 5 years”. Vials with either printed age range can be used for people 6 months through 4 years of age.
Refer to: Pfizer Dear Healthcare Provider Letter: Maroon Cap and Package Label Discrepancy and Pfizer-BioNTech Healthcare Provider Fact Sheet 6m-4y Maroon Cap for further details.
V-safe reminder for children
Encourage parents and guardians to enroll their children in the CDC V-safe After Vaccination Health Checker and complete health check-ins on their behalf after COVID-19 vaccination. V-safe is one of the many surveillance systems to monitor safety post-clinical trials. Parents will need a smartphone and their child’s vaccination card to complete separate registrations for each child. Enrollment is easy and can be completed during the waiting period immediately after vaccination. Additional resources can be found at: V-safe Print Resources.
Moderna COVID-19 vaccine trainings
Starting June 28, Moderna will be hosting weekly webinars detailing important label updates to the Moderna COVID-19 vaccine. The same topics will be covered in all webinars. Registration information can be found here: Updates to Moderna COVID-19 Vaccine.
On June 23, the ACIP will be meeting to discuss recommendations for the recently authorized Moderna COVID-19 vaccine for ages 6-17 years. The meeting agenda and materials can be found at ACIP Meeting Information. MDH’s resources and protocols will be updated pending CDC recommendations and will be posted on COVID-19 Vaccine Providers.
|
